Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.
about
Pseudogenes regulate parental gene expression via ceRNA networkCompeting endogenous RNA networks in human cancer: hypothesis, validation, and perspectivesCompeting endogenous RNA in cancer: a new pattern of gene expression regulationPseudogenes in Human CancerCirculating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewLong Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical TranslationCompeting endogenous RNA networks: tying the essential knots for cancer biology and therapeuticsRegistered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biologyProtein-Coding Genes' Retrocopies and Their Functions.Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancerGenome annotation for clinical genomic diagnostics: strengths and weaknessesCo-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.Endogenous microRNA sponges: evidence and controversy.Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes.Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progressionRole of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancerLncRNAs: From Basic Research to Medical ApplicationLncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinomaThe Emerging Function and Mechanism of ceRNAs in Cancer.Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia.The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer.Independent Tumor Origin in Two Cases of Synchronous Bilateral Clear Cell Renal Cell Carcinoma.Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis.Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC.Downregulated pseudogene CTNNAP1 promote tumor growth in human cancer by downregulating its cognate gene CTNNA1 expression.Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives.Study strategies for long non-coding RNAs and their roles in regulating gene expression.ceRNA in cancer: possible functions and clinical implications.A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.Pseudogene-expressed RNAs: a new frontier in cancers.PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis.Perspectives of long non-coding RNAs in cancer.Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma.T-ALL and thymocytes: a message of noncoding RNAsLong Noncoding RNA HOTAIR Controls Cell Cycle by Functioning as a Competing Endogenous RNA in Esophageal Squamous Cell Carcinoma.Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population.The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.
P2860
Q26738904-5CBC8ECF-F984-4C80-A385-6BFFC640AE12Q26766245-70C3CDFF-FC2B-4255-865B-66A2A07311FDQ26771833-2B5378E9-6CA1-4435-944F-B1A332E49382Q26781044-46F958CF-03A8-4602-BA6B-C0AE11E885D7Q26785539-266F3000-2116-40A7-8C76-7F847F9E9468Q28071872-B9AA2A28-B828-463D-AAE9-41C03447D130Q28088356-1A024AE7-3755-49C0-B563-4E2249A8ECF9Q28608111-7D0761A3-3269-4112-8AE3-60E07C1C6EC5Q33613535-396264D4-9E57-4094-868D-E45E2692575CQ33688531-997CB8B6-7A3F-43CA-BBAD-D62E8373B5D2Q33737782-1EF3A276-64A5-4BF6-87CF-431AE5685897Q33873637-90C73EEC-2946-41FD-9AD4-9CE5B3ED8EEBQ34463863-A7A2C8CB-3544-4E82-BD06-538F97D6D43FQ34520689-308B24B2-E9C9-4E76-B07D-A87EC1A39914Q35919690-164BEA31-DDBB-43B5-ACEE-FA4BB27EF59AQ35930137-7674CAD1-3D1D-4C0A-BA0B-E64F08360863Q36276986-C4FA1084-213C-49C8-A2A8-0149B50FCB39Q36331304-2799C5F5-5863-4039-87E9-7B70AAB7741AQ36545946-1D817E4C-F19E-44E3-A766-890D5DDD8679Q36723203-2E9E83D0-FDCD-4297-884D-EEB938CE4902Q36835382-71FDD099-5E37-4B1E-B434-5F0584C891DEQ36919280-4404CA24-1342-4AD3-B2E9-97235D752683Q37072963-53194809-5449-446D-BD20-F64564210646Q37565147-C8847FB8-E075-4D41-94DD-D6AFB727004BQ37598887-8613C476-CE80-4AE6-8496-31CDD3CFD57BQ37688264-7FF5367E-3A49-44EF-8BBF-D7CA5D217697Q38325485-67909A6A-E1F3-41D9-A4F5-C39FF52A9DEAQ38552806-11005105-A6F9-45ED-9D64-523E558A7759Q38584497-21B589D3-8366-4444-827F-55EB59D66970Q38637596-22F8FF69-27AC-490D-8CF7-0CAB2A1735A3Q38667912-3C28CADD-3830-4A9C-B434-1D74CEC029C2Q38668324-B31A593C-4820-4547-A5D2-EF48530975A3Q38732979-BA655F0F-EA45-4B35-B956-E8B2FD3E9EB5Q38752641-78AF1E41-FD64-4B2F-9D36-28E9F5F4F35AQ38784573-A0177DE3-20FC-4364-9600-73AB067DEE91Q39166891-74C32F8E-BD90-4802-AEC3-6A7B8F692C3DQ40462543-5292D17C-C0F1-4BC0-872B-C9EA1E0FA5C5Q41432729-34ED83FF-E68F-4F29-B038-ABB2892B1D81Q41592648-2BD91AB6-8D7B-44C8-B308-F1B29D3732BAQ41899812-E8E9BC0E-10FE-4730-9FAF-17FB3388416C
P2860
Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@ast
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@en
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@nl
type
label
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@ast
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@en
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@nl
prefLabel
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@ast
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@en
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@nl
P2093
P2860
P1476
Pseudogene PTENP1 functions as ...... al cell carcinoma progression.
@en
P2093
Haibing Xiao
Kiranmai Gumireddy
Qihong Huang
P2860
P304
P356
10.1158/1535-7163.MCT-14-0245
P577
2014-09-23T00:00:00Z